Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Net Income towards Common Stockholders: 2020-2024

Historic Net Income towards Common Stockholders for Krystal Biotech (KRYS) over the last 5 years, with Dec 2024 value amounting to $89.2 million.

  • Krystal Biotech's Net Income towards Common Stockholders rose 192.12% to $79.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.9 million, marking a year-over-year increase of 279.88%. This contributed to the annual value of $89.2 million for FY2024, which is 715.58% up from last year.
  • As of FY2024, Krystal Biotech's Net Income towards Common Stockholders stood at $89.2 million, which was up 715.58% from $10.9 million recorded in FY2023.
  • Krystal Biotech's Net Income towards Common Stockholders' 5-year high stood at $89.2 million during FY2024, with a 5-year trough of -$140.0 million in FY2022.
  • Over the past 3 years, Krystal Biotech's median Net Income towards Common Stockholders value was $10.9 million (recorded in 2023), while the average stood at -$13.3 million.
  • Per our database at Business Quant, Krystal Biotech's Net Income towards Common Stockholders slumped by 116.28% in 2021 and then surged by 715.58% in 2024.
  • Over the past 5 years, Krystal Biotech's Net Income towards Common Stockholders (Yearly) stood at -$32.2 million in 2020, then plummeted by 116.28% to -$69.6 million in 2021, then slumped by 101.20% to -$140.0 million in 2022, then spiked by 107.81% to $10.9 million in 2023, then skyrocketed by 715.58% to $89.2 million in 2024.